ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L01FA" (9)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Rituximab (L01FA01) 8 products WHO-DDD  
L IP  Rixathon 500 mg/50 ml 1051.321159.8010 %Concentrate for infusion: Rituximabum 500mg / 50mlSandoz
Pharmaceuticals AG
A / SL / SG
L IP  Rixathon 100 mg/10 ml2421.97475.3510 %Concentrate for infusion: Rituximabum 100mg / 10mlSandoz
Pharmaceuticals AG
A / SL / SG
L IP  Ruxience 100 mg/10 ml 203.40237.6510 %Concentrate for infusion: Rituximabum 100mg / 10mlPfizer AGA / SL / SG
L IP  Ruxience 100 mg/10 ml2 x 1421.97475.3510 %Concentrate for infusion: Rituximabum 100mg / 10mlPfizer AGA / SL / SG
     Ituxredi 500 mg/ 50 ml k.A.Concentrate for infusion: Rituximabum 500mg / 50mlDr. Reddy's
Laboratories SA
A
     Ituxredi 100 mg/ 10 ml2k.A.Concentrate for infusion: Rituximabum 100mg / 10mlDr. Reddy's
Laboratories SA
A
  IP  Rixathon 500 mg/50 ml2k.A.Concentrate for infusion: Rituximabum 500mg / 50mlSandoz
Pharmaceuticals AG
A
  IP  Rixathon 100 mg/10 ml3k.A.Concentrate for infusion: Rituximabum 100mg / 10mlSandoz
Pharmaceuticals AG
A
Obinutuzumab (L01FA03) 1 products WHO-DDD  
L IP  Gazyvaro 1000 mg/40 mlDurchstechflasche(n)3045.013328.0510 %Concentrate for infusion: Obinutuzumabum 1000mg / 40mlRoche Pharma
(Schweiz) AG
A / SL
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home